Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Jiangsu Hengrui Pharmaceuticals Co Ltd
Operating Income
Jiangsu Hengrui Pharmaceuticals Co Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Operating Income
¥3.6B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
10%
|
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Operating Income
¥7.7B
|
CAGR 3-Years
12%
|
CAGR 5-Years
16%
|
CAGR 10-Years
23%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Operating Income
¥3.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Operating Income
¥3.3B
|
CAGR 3-Years
22%
|
CAGR 5-Years
22%
|
CAGR 10-Years
21%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Operating Income
¥3.7B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
6%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Operating Income
¥787.7m
|
CAGR 3-Years
32%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
See Also
What is Jiangsu Hengrui Pharmaceuticals Co Ltd's Operating Income?
Operating Income
3.6B
CNY
Based on the financial report for Sep 30, 2023, Jiangsu Hengrui Pharmaceuticals Co Ltd's Operating Income amounts to 3.6B CNY.
What is Jiangsu Hengrui Pharmaceuticals Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
10%
Over the last year, the Operating Income growth was 42%. The average annual Operating Income growth rates for Jiangsu Hengrui Pharmaceuticals Co Ltd have been -17% over the past three years , -3% over the past five years , and 10% over the past ten years .